Microcrystalline cellulose, a direct compression binder in a quality by design environment--a review

Int J Pharm. 2014 Oct 1;473(1-2):64-72. doi: 10.1016/j.ijpharm.2014.06.055. Epub 2014 Jun 30.

Abstract

The ICH quality vision introduced the concept of quality by design (QbD), which requires a greater understanding of the raw material attributes, of process parameters, of their variability and their interactions. Microcrystalline cellulose (MCC) is one of the most important tableting excipients thanks to its outstanding dry binding properties, enabling the manufacture of tablets by direct compression (DC). DC remains the most economical technique to produce large batches of tablets, however its efficacy is directly impacted by the raw material attributes. Therefore excipients' variability and their impact on drug product performance need to be thoroughly understood. To help with this process, this review article gathers prior knowledge on MCC, focuses on its use in DC and lists some of its potential critical material attributes (CMAs).

Keywords: Binder; Calcium phosphate dibasic dihydrate (PubChem CID: 104805); Critical material attributes; Direct compression; Lactose monohydrate (PubChem CID: 62223); Magnesium stearate (PubChem CID: 11177); Microcrystalline cellulose; Microcrystalline cellulose (PubChem CID: 14055602); Quality by design; Tablets.

Publication types

  • Review

MeSH terms

  • Cellulose / chemistry*
  • Drug Compounding / methods
  • Excipients / chemistry*
  • Quality Control
  • Tablets

Substances

  • Excipients
  • Tablets
  • Cellulose
  • microcrystalline cellulose